ORMP has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
ORMP has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).
Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.
Oramed Pharmaceuticals's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.
For the Biotechnology subindustry, Oramed Pharmaceuticals's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Oramed Pharmaceuticals's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:
* The bar in red indicates where Oramed Pharmaceuticals's Margin of Safety % (DCF Earnings Based) falls into.
Thank you for viewing the detailed overview of Oramed Pharmaceuticals's Margin of Safety % (DCF Earnings Based) provided by GuruFocus.com. Please click on the following links to see related term pages.
Benjamin Shapiro | director | 1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK NY 10036 |
Nadav Kidron | director, 10 percent owner | 142 W. 57TH ST., NEW YORK NY 10019 |
Yadin Rozov | director | 9 TERRACE CIRCLE, ARMONK NY 10504 |
Miriam Kidron | director | 2 ELZA STREET, JERUSALEM L3 93706 |
Michael Rabinowitz | officer: Chief Commercial Officer | 1185 AVENUE OF THE AMERICAS, THIRD FLOOR, NEW YORK NY 10036 |
Arie Mayer | director | MORAN 16, KFAR SABA L3 4428890 |
Netanel Derovan | officer: Chief Legal Officer | 1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK NY 10036 |
David Silberman | officer: Chief Financial Officer | 20 MAMILLA AVENUE, JERUSALEM L3 9414904 |
Kevin Rakin | director | 36 CHURCH LANE, WESTPORT CT 06880 |
Michael Rabinowitz | officer: Chief Commercial Officer | MAXIM GROUP, LLC, 405 LEXINGTON AVENUE, NEW YORK NY 10174 |
Leonard Sank | director | 3 BLAIR ROAD, CAPE TOWN T3 8005 |
Gao Xiaoming | director | 11F. NO. 266 HANKOU ROAD, HUANGPU DISTRICT, SHANGHAI F4 2000001 |
Avraham Gabay | officer: CFO, Treasurer and Secretary | 2/4 HIGH-TECH PARK, P.O. BOX 39098, JERUSALEM L3 91390 |
Mark Daniel Hasleton | officer: VP Business Development | 13, HIBAT ZION, RAANANA, RAANANA L3 4338111 |
Aviad Friedman | director | HADASSA 6, TEL AVIV L3 6451306 |
From GuruFocus
By PRNewswire PRNewswire • 06-27-2022
By PRNewswire PRNewswire • 05-01-2023
By PRNewswire PRNewswire • 06-03-2022
By PRNewswire • 09-22-2023
By PRNewswire PRNewswire • 06-11-2022
By PRNewswire PRNewswire • 12-21-2022
By PRNewswire PRNewswire • 06-21-2022
By PRNewswire PRNewswire • 02-09-2023
By PRNewswire PRNewswire • 07-07-2022
By PRNewswire PRNewswire • 06-23-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.